- Drug Pipelines
- July 2020
- 61 Pages
Global
From €3121EUR$3,500USD£2,717GBP
- Drug Pipelines
- July 2020
- 1191 Pages
Global
From €2229EUR$2,500USD£1,941GBP
- Drug Pipelines
- July 2020
- 222 Pages
Global
From €1783EUR$2,000USD£1,553GBP
- Drug Pipelines
- December 2019
- 32 Pages
Global
From €3121EUR$3,500USD£2,717GBP
- Report
- June 2025
- 122 Pages
Australia
From €3565EUR$3,999USD£3,104GBP
- Report
- June 2025
- 120 Pages
India
From €3120EUR$3,499USD£2,716GBP
- Report
- June 2025
- 119 Pages
Thailand
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 145 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 148 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 145 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 139 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 137 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 138 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 142 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 144 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 142 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 147 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 146 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- March 2025
- 138 Pages
Global
From €3565EUR$3,999USD£3,104GBP
- Report
- February 2025
- 150 Pages
Global
From €3565EUR$3,999USD£3,104GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more